# Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis

> **NCT02078882** · PHASE4 · COMPLETED · sponsor: **Christopher Bowlus, MD** · enrollment: 16 (actual)

## Conditions studied

- Primary Biliary Cirrhosis

## Interventions

- **BIOLOGICAL:** abatacept

## Key facts

- **NCT ID:** NCT02078882
- **Lead sponsor:** Christopher Bowlus, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078882, "Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02078882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*